90 related articles for article (PubMed ID: 38041093)
1. The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
Wei W; Shi F; Xu Y; Jiao Y; Zhang Y; Ou Q; Wu X; Yang L; Lai J
J Transl Med; 2023 Dec; 21(1):874. PubMed ID: 38041093
[TBL] [Abstract][Full Text] [Related]
2. ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.
Vokes NI; Galan Cobo A; Fernandez-Chas M; Molkentine D; Treviño S; Druker V; Qian Y; Patel S; Schmidt S; Hong L; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee JJ; Negrao MV; Gibbons DL; Vaporciyan A; Le X; Wu J; Zhang J; Rigney U; Iyer S; Dean E; Heymach JV
Clin Cancer Res; 2023 Dec; 29(23):4958-4972. PubMed ID: 37733794
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Ricciuti B; Elkrief A; Alessi J; Wang X; Li Y; Gupta H; Muldoon DM; Bertram AA; Pecci F; Lamberti G; Di Federico A; Barrichello A; Vaz VR; Gandhi M; Lee E; Shapiro GI; Park H; Nishino M; Lindsay J; Felt KD; Sharma B; Cherniack AD; Rodig S; Gomez DR; Shaverdian N; Rakaee M; Bandlamudi C; Ladanyi M; Janne PA; Schoenfeld AJ; Sholl LM; Awad MM; Cheng ML
Clin Cancer Res; 2023 Jul; 29(13):2540-2550. PubMed ID: 37097610
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Hwang J; Shi X; Elliott A; Arnoff TE; McGrath J; Xiu J; Walker P; Bergom HE; Day A; Ahmed S; Tape S; Makovec A; Ali A; Shaker RM; Toye E; Passow R; Lozada JR; Wang J; Lou E; Mouw KW; Carneiro BA; Heath EI; McKay RR; Korn WM; Nabhan C; Ryan CJ; Antonarakis ES
Clin Cancer Res; 2023 Jul; 29(14):2702-2713. PubMed ID: 37126020
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer.
Weber AM; Drobnitzky N; Devery AM; Bokobza SM; Adams RA; Maughan TS; Ryan AJ
Oncotarget; 2016 Sep; 7(38):60807-60822. PubMed ID: 27602502
[TBL] [Abstract][Full Text] [Related]
6. Identification of ATM Mutation as a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy.
Cui S; Chen T; Zhao Y; Xiao Z; Liu M; Huang X; Cao S; Zhou R; Li Y; Huo X; Wang N
Curr Cancer Drug Targets; 2024; 24(5):501-509. PubMed ID: 38804343
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.
Ma J; Setton J; Morris L; Albornoz PB; Barker C; Lok BH; Sherman E; Katabi N; Beal K; Ganly I; Powell SN; Lee N; Chan TA; Riaz N
Oncotarget; 2017 Feb; 8(6):10312-10323. PubMed ID: 28055970
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.
Mazzio EA; Lewis CA; Elhag R; Soliman KF
Cancer Genomics Proteomics; 2018; 15(4):249-264. PubMed ID: 29976630
[TBL] [Abstract][Full Text] [Related]
9. Germline
Grochot R; Carreira S; Miranda S; Figueiredo I; Bertan C; Rekowski J; Yuan W; Ferreira A; Riisnaes R; Neeb A; Gurel B; de Los Dolores Fenor de la Maza M; Guo C; Carmichael J; Westaby D; Mateo J; Sharp A; McVeigh TP; De Bono J
Eur Urol Open Sci; 2023 Jun; 52():72-78. PubMed ID: 37284046
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.
Pilié PG; Giuliani V; Wang WL; McGrail DJ; Bristow CA; Ngoi NYL; Kyewalabye K; Wani KM; Le H; Campbell E; Sanchez NS; Yang D; Gheeya JS; Goswamy RV; Holla V; Shaw KR; Meric-Bernstam F; Liu CY; Ma X; Feng N; Machado AA; Bardenhagen JP; Vellano CP; Marszalek JR; Rajendra E; Piscitello D; Johnson TI; Likhatcheva M; Elinati E; Majithiya J; Neves J; Grinkevich V; Ranzani M; Luzarraga MR; Boursier M; Armstrong L; Geo L; Lillo G; Tse WY; Lazar AJ; Kopetz SE; Geck Do MK; Lively S; Johnson MG; Robinson HMR; Smith GCM; Carroll CL; Di Francesco ME; Jones P; Heffernan TP; Yap TA
Clin Cancer Res; 2024 May; 30(10):2121-2139. PubMed ID: 38416404
[TBL] [Abstract][Full Text] [Related]
11. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
[TBL] [Abstract][Full Text] [Related]
12.
Yin M; Grivas P; Emamekhoo H; Mendiratta P; Ali S; Hsu J; Vasekar M; Drabick JJ; Pal S; Joshi M
Oncotarget; 2018 Mar; 9(24):16891-16898. PubMed ID: 29682192
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population.
Wang S; Zhang Y; Chen M; Wang Y; Feng Y; Xu Z; Zhang D; Sun Y; Fu Z
Oncotarget; 2018 Jun; 9(42):26616-26624. PubMed ID: 29928473
[TBL] [Abstract][Full Text] [Related]
14. Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.
Madubata CJ; Roshan-Ghias A; Chu T; Resnick S; Zhao J; Arnes L; Wang J; Rabadan R
NPJ Genom Med; 2017; 2():29. PubMed ID: 29263839
[TBL] [Abstract][Full Text] [Related]
15. ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells.
Chen CW; Buj R; Dahl ES; Leon KE; Aird KM
Heliyon; 2020 Sep; 6(9):e05097. PubMed ID: 33024871
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.
Vallabhaneni E; Kareff SA; Barnett RM; Drusbosky LM; Dalal S; Raez LE; Santos ES; Albrecht F; Cusnir M; Rodriguez E
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539485
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Associations of Co-occurrence of
Liu J; Liu S; Li D; Li H; Zhang F
Glob Med Genet; 2024 Jun; 11(2):150-158. PubMed ID: 38628662
[No Abstract] [Full Text] [Related]
18. Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.
Subbiah V; Bupathi M; Kato S; Livingston A; Slopis J; Anderson PM; Hong DS
Oncoscience; 2015; 2(7):646-58. PubMed ID: 26328274
[TBL] [Abstract][Full Text] [Related]
19.
Thu KL; Yoon JY
Transl Lung Cancer Res; 2024 Mar; 13(3):699-705. PubMed ID: 38601449
[No Abstract] [Full Text] [Related]
20. Novel targets for ATM-deficient malignancies.
Winkler J; Hofmann K; Chen S
Mol Cell Oncol; 2014; 1(1):e29905. PubMed ID: 27308314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
